Transaction solidifies the formation of a new industry leader providing highly engineered products to the aerospace and defense markets “The creation of Velocity One follows a multi-year thematic ...
Baxter announces that it will partner with Mayo Clinic and Velocity Pharmaceutical to form Vitesse Biologics, a Baxalta-managed company focused on immunology, hematology, and oncology. On June 1, 2015 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback